Revenue

Seattle startup CounterX Therapeutics to present its novel overdose prevention drug at a top investor event, signaling new hope in the fentanyl crisis.

Alibaba's Accio Work deploys AI "business teams" to SMEs, managing e-commerce and even launching physical products from scratch for a new era of business.

A new national ranking moves beyond funding and publications to reveal which U.S. research institutions are truly effective at creating real-world cures.

A new advisory firm is tackling the opaque world of aesthetic device sales, promising to save providers up to $80,000 on high-ticket equipment.

Once a hospital disinfectant, hypochlorous acid is now a skincare star. Magic Molecule's massive CVS launch signals a major shift in the beauty industry.

Insiders gain 97.7% voting control with just 2.4% of shares, installing new leadership to transform the logistics firm through aggressive acquisitions.

As cargo capacity shrinks and tensions rise, FedEx leverages new routes and digital tools to keep critical medical supplies moving across the Middle East.

Italian biopharma giant Chiesi makes its largest acquisition ever, targeting KalVista's groundbreaking oral HAE drug to reshape patient care and its future.

A new partnership will allow consumers to spend stablecoins and Bitcoin at 175M+ locations, blurring the lines between digital wallets and everyday commerce.

Snap CEO Evan Spiegel will headline Augmented World Expo, unveiling new tools from subsidiary Specs Inc. and charting a course for human-empowered spatial AI.

A startling report shows most banks struggle to measure marketing ROI, citing outdated tech and compliance hurdles. Is specialized affiliate marketing the answer?

The largest deal in epigenetic testing sees TruDiagnostic's parent buy Dr. David Sinclair's Tally Health, aiming to make personalized longevity mainstream.

The U.S. Highbush Blueberry Council is betting on startups to find new uses for blueberries in everything from skincare to pet food. Here's what's next.

With a new industry giant on its board and fresh funding, Phagenesis is set to scale its groundbreaking neuromodulation therapy for swallowing disorders.

NBA star Russell Westbrook's new ad tech platform aims to revolutionize marketing by putting authentic cultural intelligence at the core of its strategy.

A new report shows most procurement and IT teams collaborate, but a failure on AI governance is stalling deployment and creating enterprise-wide risk.

With huge energy needs, Israel's water company Mekorot turns to nT-Tao's fusion tech in a bold move that could redefine national infrastructure resilience.

As AI and usage-based pricing complicate finance, BillingPlatform launches RevVenue, an expert-led hub to help firms navigate a new era of compliance risk.

With new sensors that defy magnetic interference and a key investment from Plug and Play, XELA Robotics is set to revolutionize industrial automation in America.

The trading signal provider is rolling out new automated tools, touting major Q1 gains. But how do its claims stack up in a competitive, skeptical market?